Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri, Fadi; Hourmant, Maryvonne; Campistol, Josep M; Cataland, Spero R; Espinosa, Mario; Gaber, A Osama; Menne, Jan; Minetti, Enrico E; Provôt, François; Rondeau, Eric; Ruggenenti, Piero; Weekers, Laurent E; Ogawa, Masayo; Bedrosian, Camille L; Legendre, Christophe M.
Am J Kidney Dis; 68(1): 84-93, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27012908